Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05196269Not ApplicableActive Not Recruiting

Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.

Role: collaborator

NCT02262221Not ApplicableSuspended

Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer

Role: collaborator

NCT04452240Unknown

Safety, Efficacy and Cost Analysis of the Conformable Thoracic Stent Graft With ACTIVE CONTROL

Role: collaborator

NCT03512015Not ApplicableUnknown

A Mobile Supportive Care App for Patients With Metastatic Lung Cancer

Role: lead

NCT01589965Early Phase 1Unknown

The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho

Role: lead

All 5 trials loaded